Chart, page-4254

First 4254 Last

Share
Profile

Follow
itsagas

13,064 Posts.

1353

21/10/21

09:38

Post #: 56958251
Share

Originally posted by mephistophles: ↑

Hey @George1972 @samfiodiving,

My opinion largely irrelevant (~500k shares and not as cluey as you lot), but I have to agree with a large deal being the desired outcome here. I'm not particularly fussed if there's a CR in the 30-40c region, although George makes an excellent point re risk mitigation that's given me some pause.

Anyway, that's not the point of this message...

I'm actually quite curious as to what you guys imagine happening with the potential PRV, if there is indeed a deal waiting?

In my limited (hence querying) experience, these are usually designated to be sold and the proceeds split evenly, but I've only seen this in deals where the big-fish is taking complete rights for drug A in region X. I don't imagine us doing a deal like that with ATL1102 UNLESS IT'S ABSOLUTELY MASSIVE, because mgmt know that we're potentially sitting on a platform drug?

i.e. A deal would more likely be centred around ATL1102, specifically for the treatment of DMD, in regions x and y?

Not sure if that might change anything with respect to the usual "split the proceeds from the sale of the PRV" line?

Cheers.

p.s. Tangentially, it could be quite interesting if [select-your-partner] runs the trial and we get access to the data for ROW. Apparently Asia (particularly Japan) is emerging as a profitable rare disease market. I assume we'd all like to see Aussie boys benefit from ATL1102 ASAP too

Expand

Here’s the thing

Large Funds and Pharmas waiting on the sidelines
EMA approval validates Atl1102
A 12 month study will end up in commercialisation$$

Now: A 12 month study with the same end points already proven in our last DMD trial..

No Brainer

Thats all everyone is waiting for Funds Pharmas etc

Share Price won’t be crawling.. will go up in 5/10 cents lots ..

Whatever you do.. Don’t sell!
Cr will only help expand the Anp pipeline…$$

ANP Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
16 Upvote

0 Great analysis

Reply

Top Stories

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

STX

Strike Energy secures $153 million for Perth Basin gas projects

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

There are more pages in this discussion • 1,652 more messages in this thread...

First 4254 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.1¢		Change -0.006(6.90%)		Mkt cap ! $73.02M

Open	High	Low	Value	Volume
8.7¢	8.7¢	8.1¢	$154.2K	1.820M

Buyers (Bids)

No.	Vol.	Price($)
2	33824	8.1¢

Sellers (Offers)

Price($)	Vol.	No.
8.4¢	275242	2

View Market Depth

No.	Vol.	Price($)
2	33824	0.081
5	18604	0.080
1	100200	0.079
2	121300	0.077
1	130000	0.076

Price($)	Vol.	No.
0.084	275242	2
0.085	4326	1
0.089	102263	2
0.090	553175	3
0.091	108000	1

Last trade - 16.10pm 24/06/2024 (20 minute delay)

PER (ASX) Chart

Chart, page-4254

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Strike Energy secures $153 million for Perth Basin gas projects

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

Cultural heritage agreement puts Walford Creek exploration back on the map

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Chart, page-4254

Top Stories

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Strike Energy secures $153 million for Perth Basin gas projects

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

Cultural heritage agreement puts Walford Creek exploration back on the map

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News